The short version
- Why people research itSoft-tissue and gut repair, reduced inflammation, angiogenesis and faster recovery from injury.
- What the evidence isThere is no controlled human trial of this compound.
- What to watchFever, rash or joint pain.
How Trekrezan works
An ammonium salt pairing a tri-hydroxyethyl cation with a substituted phenoxyacetic acid anion, belonging to the protatranes — the proton-centered members of the atrane family developed at Irkutsk by Voronkov's school. It contains no silicon, despite frequently being described in the market as an organosilicon agent. The published immunology is bidirectional in the same abstract: decreased spot-forming activity of polypotent stem blood cells alongside stimulated lympho- and hemopoiesis, antibody formation and direct stimulation of human B lymphocyte proliferation in vitro.
The chemistry is a family most readers have never heard of, and naming it correctly is the start. Trekrezan is tris(2-hydroxyethyl)ammonium methylphenoxyacetate — an ammonium salt pairing a tri-hydroxyethyl cation with a substituted phenoxyacetic acid anion.
The claimed mechanism is immunomodulation, and the word is doing a lot of work. Shirinskii 1993 reports that in vivo the compound decreased the spot-forming activity of polypotent stem blood cells while stimulating lympho- and hemopoiesis, antibody formation and showing steady anti-inflammatory activity, and that in vitro it stimulated human mononuclear cell proliferation through direct action on B lymphocytes with increased lymphokine and monokine production.
- Oral
On the goal map: Innate immunity & trained immunity (Immune resilience)
Research on Trekrezan6 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Four studies, all from one school, all in mice or cells. No controlled human trial exists.
Human clinical evidence
There is no controlled human trial of this compound. Not a trial, not a case series, not a tolerability report. A PubTator3 search on 9 September 2026 returns 24 records of which four are on topic, and every one of them is in mice or in cells.
No completed human trial
Correlative data
Every published study across thirty-three years carries an author from one institution. Voronkov appears on the 2003, 2004 and 2010 papers and on the 1993 immunology work with the Novosibirsk group, and the 2021 chemistry review is explicitly an account of that school's contribution (Kondratenko 2021). Independent replication is how a finding stops being one laboratory's opinion, and it has not happened.
The name changed and the older one finds different papers. The same molecule was published as crezacine — a 1985 study of exocrine pancreatic activity and a 2000 paper on microbiological synthesis — neither of which the current brand name retrieves.
How the mechanism reads
An ammonium salt pairing a tri-hydroxyethyl cation with a substituted phenoxyacetic acid anion, belonging to the protatranes, the proton-centered members of the atrane family. It contains no silicon, despite the market describing it as organosilicon.
MechanisticThe 1993 work reports decreased spot-forming activity of polypotent stem blood cells alongside stimulated lympho- and hemopoiesis, antibody formation, steady anti-inflammatory activity, and direct stimulation of human B lymphocyte proliferation in vitro (Shirinskii 1993). A claim that a substance raises what is low and lowers what is high cannot be falsified by any single measurement.
Experimental, animal or cellPredicted downside from its own efficacy claim: if it really stimulates antibody production (Voronkov 2004), the people it suits least are those with antibody-mediated autoimmune disease and those on transplant immunosuppression. Neither group has been studied and no vendor names them.
Mechanistic
Sources
- Shirinskii VS, Kolesnikova OP, Kudaeva OT, et al. [The immunoactive properties of trekrezan]. Eksperimentalnaia i Klinicheskaia Farmakologiia 1993 [Russian] · PMID 8219991
- Voronkov MG, Pavel YG, Karus AL, et al. Effect of trekrezan on immunogenesis under experimental conditions. Bulletin of Experimental Biology and Medicine 2004 · PMID 15662463
- Kolesnikova OP, Kudaeva OT, Sukhenko TG, et al. Trekrezan as a modulator of hemato- and immunopoieses. Doklady Biological Sciences 2003 · PMID 14556517
- Voronkov MG, Nurbekov MK, Bobkova SN, et al. Antisclerotic effect of Trekrezan and its possible mechanisms. Doklady Biochemistry and Biophysics 2010 · PMID 20514866
- Kondratenko YA. Contribution of the Scientific School of Academician M.G. Voronkov to the Development of the Chemistry of Biologically Active Atranes (Protatranes and Hydrometallatranes). Russian Journal of General Chemistry 2021 · PMID 35068915
- Todorova V. Plant Adaptogens - History and Future Perspectives. Nutrients 2021 · PMID 34445021
Trekrezan safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- An immune condition you are managing: published immune effects run both ways within the same abstract.
- Anti-rejection drugs after a transplant: immune effects of this salt in mice run both ways.
- Pregnancy or breastfeeding: only mouse and cell studies exist.
- Sensitivity to ethanolamine-type compounds, since the cation is a triethanolamine derivative.
- Expecting an organosilicon: it contains no silicon despite how it is marketed.
What’s expected
- Unknown in people; no controlled human trial exists.
- Possible mild stomach upset.
- Any immune effect could push counts up or down.
Watch for
- Fever, rash or joint pain.
- A flare of an autoimmune condition.
- Persistent infections.
- Hives or breathing trouble while using Trekrezan.
Labs that tell you it’s working
- Complete Blood Count (CBC) w/ Differential
- hs-CRP (C-Reactive Protein, High Sensitivity)
- TNF-Alpha (Tumor Necrosis Factor)
- Comprehensive Metabolic Panel (CMP)
A protatrane salt of triethanolammonium and phenoxyacetic acid, with four mouse and cell studies from one school; it is not silicon-based. PMID 15662463 PMID 14556517
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Trekrezan FAQ4 common questions
- Is Trekrezan approved for human use?
- No. Trekrezan is a research compound. No completed randomized human trial has given it yet.
- What is Trekrezan researched for?
- Soft-tissue and gut repair, reduced inflammation, angiogenesis and faster recovery from injury.
- Which labs show whether it's doing anything?
- Complete Blood Count; hs-CRP; TNF-Alpha; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Trekrezan: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



